Equities

R1 RCM Inc

R1 RCM Inc

Actions
Health CareHealth Care Providers
  • Price (USD)14.15
  • Today's Change-0.03 / -0.21%
  • Shares traded3.49m
  • 1 Year change-11.56%
  • Beta0.8528
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.

  • Revenue in USD (TTM)2.38bn
  • Net income in USD-40.00m
  • Incorporated2022
  • Employees29.40k
  • Location
    R1 RCM Inc434 W. Ascension Way, 6Th FloorMURRAY 84123United StatesUSA
  • Phone+1 (312) 324-7820
  • Fax+1 (302) 655-5049
  • Websitehttps://www.r1rcm.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
RCM:NSQ since
announced
Transaction
value
Acclara Solutions LLCDeal completed06 Dec 202306 Dec 2023Deal completed28.75%680.73m
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Amedisys Inc2.29bn91.98m3.18bn19.00k34.742.8327.361.392.802.8069.6534.371.12--7.20120,506.604.487.826.0210.3944.0343.634.015.89--9.620.24820.000.5936.11-108.22--14.16--
Hims & Hers Health Inc1.07bn18.10m3.53bn1.05k217.419.77118.593.310.0750.0754.821.672.456.13225.781,020,207.004.16--5.21--82.19--1.70--2.30--0.00--65.49--64.15------
Surgery Partners Inc2.89bn-33.80m4.09bn10.50k--2.0915.871.42-0.2682-0.268222.9515.360.409527.915.94275,142.801.831.172.551.6326.9726.334.473.031.692.520.464--8.039.1478.21--17.41--
Select Medical Holdings Corp6.87bn258.77m4.59bn38.40k16.943.248.360.66782.082.0855.3110.890.8825--6.73178,985.004.304.195.345.4614.4213.984.875.11--3.960.678415.305.225.5753.0311.986.50--
Sotera Health Co1.10bn39.86m4.74bn3.00k119.4811.2123.794.320.14010.14013.881.490.35819.857.81366,062.001.31-0.8681.39-0.966455.1854.403.65-2.682.592.230.8459--4.547.06121.87--24.24--
Radnet Inc1.71bn9.92m4.96bn7.87k457.065.6328.502.900.14680.146824.5211.910.5775--8.14217,704.801.431.241.831.6622.8221.562.481.86--1.520.48440.0013.0510.64-71.42-37.6319.60--
Option Care Health Inc4.59bn211.31m5.32bn5.81k26.073.7819.451.161.191.1925.948.231.3813.2310.62790,263.806.343.637.974.3521.5522.454.602.781.367.040.44070.009.0643.4277.40--24.72--
CorVel Corp816.78m78.02m5.40bn4.87k70.0020.4551.606.614.504.5047.1315.411.81--8.98167,716.6017.2714.8730.2824.2121.7922.149.559.16----0.000.0010.685.9514.9010.5713.87--
R1 Rcm Inc2.38bn-40.00m5.99bn29.40k--2.1222.872.52-0.0956-0.09565.446.680.4393--5.8780,942.18-0.73841.35-0.79221.5320.4520.09-1.681.96--1.660.4453--24.7921.02105.21--25.07--
PACS Group Inc-100.00bn-100.00bn6.33bn32.43k--10.87----------3.75----------------------------0.4792--28.47---25.00------
Acadia Healthcare Company Inc3.06bn-5.12m7.24bn23.50k--2.4249.922.37-0.0725-0.072533.3732.210.5647--8.32179,836.800.07052.320.07922.64----0.12495.601.175.440.3754--12.208.99-107.93--3.34--
Ensign Group Inc3.97bn225.40m8.62bn35.30k38.695.2028.392.173.903.9068.7529.050.9458--7.99112,397.305.396.456.437.8821.3622.325.696.48--354.480.08156.5623.2716.28-6.8028.624.405.02
Chemed Corp2.34bn300.92m8.69bn15.09k29.307.1723.933.7219.7219.72153.0180.511.44133.4215.30154,805.9018.5719.5322.4924.6435.9634.6012.8812.601.73--0.008.156.064.909.175.801.466.10
Data as of Sep 19 2024. Currency figures normalised to R1 RCM Inc's reporting currency: US Dollar USD

Institutional shareholders

18.19%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 202415.05m3.57%
The Vanguard Group, Inc.as of 30 Jun 202414.68m3.48%
Coliseum Capital Management LLCas of 30 Jun 202410.28m2.44%
Voss Capital LPas of 30 Jun 20246.71m1.59%
Hawk Ridge Capital Management LPas of 30 Jun 20246.28m1.49%
P2 Capital Partners LLCas of 30 Jun 20245.40m1.28%
SSgA Funds Management, Inc.as of 30 Jun 20245.38m1.28%
Melqart Asset Management (UK) Ltd.as of 30 Jun 20244.83m1.14%
Paradigm Capital Management, Inc.as of 30 Jun 20244.45m1.06%
American Century Investment Management, Inc.as of 30 Jun 20243.73m0.88%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.